![]() |
市場調查報告書
商品編碼
1871942
全球虛擬實境治療環境市場:預測至2032年-按治療類型、交付方式、技術、應用、最終用戶和地區進行分析Virtual-Reality Therapy Environments Market Forecasts to 2032 - Global Analysis By Therapy Type, Delivery Mode, Technology, Application, End User, and By Geography. |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球虛擬實境治療環境市場價值將達到 11 億美元,到 2032 年將達到 69 億美元,預測期內複合年成長率為 29.9%。
虛擬實境治療環境是由電腦生成的身臨其境型環境,醫療專業人員利用這些環境為患者提供心理健康、復健和疼痛管理的治療性介入。患者參與根據自身需求量身定做的受控互動場景中,從而進行暴露療法、技能訓練和認知訓練。這些環境提供即時生物回饋療法和數據分析,以改善治療效果、提高患者參與度,並提升遠距和臨床環境下的醫療服務可近性。
根據美國心理學會的說法,VR暴露療法為患者提供了一個可控、安全的環境,讓他們能夠面對和應對恐懼症和創傷後壓力症候群,其有效性也得到了臨床研究的支持。
在精神健康治療中擴大應用
隨著焦慮症、憂鬱症和創傷後壓力症候群(PTSD)的日益普遍,虛擬實境(VR)治療環境正擴大融入心理健康治療中。臨床醫生利用身臨其境型模擬技術,在可控的數位環境中提供暴露療法和壓力緩解。與傳統方法相比,這項技術提高了患者的治療參與度和依從性。此外, VR頭戴裝置和生物回饋療法技術的進步也正在改善治療效果。因此,VR在精神醫學領域的應用不斷擴展,推動全球醫療保健系統的持續發展。
設備和安裝高成本
儘管虛擬實境療法展現出令人鼓舞的成果,但高昂的初始投資仍阻礙著其廣泛應用。頭戴式設備、動作感測器和計算系統的成本給小規模診所和心理健康中心帶來了沉重的財務負擔。此外,軟體客製化和治療師培訓的需求也增加了營運成本。開發中國家嚴格的報銷政策進一步限制了其可近性。這些經濟和後勤方面的障礙持續阻礙著虛擬實境療法在整個醫療保健生態系統中的大規模應用。
擴大遠距復健計劃
在遠端醫療革命的推動下,虛擬實境(VR)療法融入遠距復健體系,開啟了無限可能。病患現在可以透過雲端基礎VR平台在家中接受指導性的認知和物理治療。這種轉變實現了持續監測和個人化自適應治療。醫療服務提供者則受益於更高的擴充性和更低的營運成本。隨著保險公司對遠距復健的接受度不斷提高,其在全球範圍內向服務不足和偏遠地區的擴展將成為推動成長的關鍵因素。
有限的臨床檢驗和接受度
虛擬實境(VR)介入措施面臨的主要挑戰仍然是缺乏臨床標準化和有限的長期療效檢驗。許多項目缺乏大規模的、經同行評審的研究來證明其療效的一致性。因此,醫療專業人員在開立身臨其境型療法處方時仍持謹慎態度。此外,患者對數位暴露療法的懷疑態度也可能阻礙其廣泛應用。如果沒有更強力的臨床支持和監管協調,該行業的信譽在未來幾年可能會受到嚴重限制。
疫情期間面對面治療的限制極大地促進了人們對虛擬治療平台的興趣。心理健康機構更依賴虛擬實境(VR)程序來遠端提供身臨其境型認知行為療法。疫情後的復甦工作進一步凸顯了數位心理健康基礎設施的重要性。此外,人們對心理健康意識提升也增強了VR長期應用的必要性。因此,新冠疫情已將VR療法從一個實驗性的小眾領域轉變為一種主流的治療選擇。
預計在預測期內,認知行為療法細分市場將佔據最大的市場佔有率。
預計在預測期內,認知行為療法領域將佔據最大的市場佔有率,這主要得益於虛擬實境技術在焦慮症、恐懼症和壓力管理介入方面的廣泛臨床應用。身臨其境型模擬能夠增加患者接觸可控壓力源的機會,從而實現可衡量的進步並培養適應性應對機制。此外,治療師還可以利用可自訂的環境來有效應對個人化的觸發因素。正在進行的研究表明,虛擬實境技術能夠改善認知功能並降低復發率,這進一步鞏固了該領域在虛擬實境治療應用方面的領先地位。
預計在預測期內,遠端/虛擬服務交付領域將實現最高的複合年成長率。
預計在預測期內,遠端/虛擬治療領域將實現最高成長率,這主要得益於雲端基礎治療平台和家用VR設備的日益普及。此模式支援持續互動,並可實現即時進度追蹤和治療師監督。寬頻普及率的提高和穿戴式裝置的整合正在改善遠距治療體驗。此外,疫情後遠端醫療政策和靈活的報銷政策正在加速患者接受遠距治療,從而推動該領域的快速擴張。
預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於醫療保健的快速數位化、心理健康意識宣傳活動以及遠距遠端醫療基礎設施的不斷完善。日本、韓國和中國等國家已在精神病院和健康中心引入虛擬實境(VR)療法。政府支持心理健康技術的舉措也進一步推動了其普及。可支配收入的成長和民眾對技術的熟練正在推動身臨其境型療法解決方案在亞太地區的應用。
在預測期內,北美預計將實現最高的複合年成長率,這主要得益於強勁的技術創新、早期臨床應用以及有利的法規結構。美國和加拿大在虛擬實境(VR)心理健康研究領域處於領先地位,這得益於大學臨床試驗和醫療保健Start-Ups的支持。與保險模式的整合以及人工智慧驅動的分析正在提高治療的精確度。此外,數位醫療公司不斷增加的投資也推動了全部區域市場的快速成長。
According to Stratistics MRC, the Global Virtual-Reality Therapy Environments Market is accounted for $1.1 billion in 2025 and is expected to reach $6.9 billion by 2032 growing at a CAGR of 29.9% during the forecast period. Virtual-Reality Therapy Environments are immersive, computer-generated settings used by healthcare professionals to deliver therapeutic interventions for mental health, rehabilitation, or pain management. Patients engage in controlled, interactive scenarios tailored to their needs, enabling exposure therapy, skills training, and cognitive exercises. The environments provide real-time biofeedback and data analytics, enhancing therapy efficacy, patient engagement, and access to care in remote or clinical contexts.
According to the American Psychological Association, VR exposure therapy is providing controlled, safe environments for patients to confront and manage phobias and PTSD, with efficacy supported by clinical studies.
Growing use in mental health treatment
Propelled by the rising prevalence of anxiety, depression, and PTSD, virtual reality (VR) therapy environments are increasingly integrated into mental health treatment. Clinicians are adopting immersive simulations to deliver exposure therapy and stress reduction in controlled digital settings. This technology enhances engagement and treatment adherence compared to traditional methods. Moreover, advancements in VR headsets and biofeedback integration improve therapeutic outcomes. Consequently, expanding psychiatric applications are fueling sustained growth across global healthcare systems.
High equipment and setup cost
Despite promising results, the widespread adoption of VR therapy is hindered by high initial investment requirements. The cost of headsets, motion sensors, and computing systems poses financial challenges for small clinics and mental health centers. Additionally, the need for software customization and therapist training adds to operational expenses. Limited reimbursement policies further restrict affordability in developing economies. These financial and logistical barriers continue to slow mass deployment across healthcare ecosystems.
Expansion in remote rehabilitation programs
Spurred by the telehealth revolution, VR therapy's integration into remote rehabilitation frameworks offers immense potential. Patients can now access guided cognitive or physical therapy sessions from home through cloud-based VR platforms. This shift enables continuous monitoring and adaptive treatment personalization. Healthcare providers benefit from improved scalability and reduced overheads. As insurers increasingly recognize tele-rehabilitation, global expansion into underserved and rural populations becomes a key growth catalyst.
Limited clinical validation and acceptance
A major challenge lies in the limited clinical standardization and long-term efficacy validation of VR-based interventions. Many programs lack large-scale, peer-reviewed studies demonstrating consistent outcomes. Consequently, medical professionals remain cautious about prescribing immersive therapies. Moreover, skepticism among patients regarding digital exposure treatments may hinder adoption. Without stronger clinical backing and regulatory alignment, industry credibility could face significant constraints over the coming years.
The pandemic dramatically accelerated interest in virtual therapy platforms due to restricted in-person sessions. Mental health facilities increasingly relied on VR programs to deliver immersive cognitive and behavioral therapies remotely. Post-pandemic recovery initiatives further emphasized digital mental healthcare infrastructure. Moreover, increased awareness of psychological well-being strengthened the case for long-term VR adoption. Thus, COVID-19 transformed VR therapy from an experimental niche to a mainstream therapeutic alternative.
The cognitive behavioral therapy segment is expected to be the largest during the forecast period
The cognitive behavioral therapy segment is expected to account for the largest market share during the forecast period, resulting from widespread clinical adoption of VR for anxiety, phobia, and stress management interventions. Immersive simulations enhance patient exposure to controlled stressors, enabling measurable progress and adaptive coping mechanisms. Moreover, therapists leverage customizable environments to address individual triggers effectively. Continued research demonstrating cognitive improvement and reduced relapse rates further consolidates this segment's dominance in therapeutic VR applications.
The remote/virtual delivery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the remote/virtual delivery segment is predicted to witness the highest growth rate, propelled by the growing availability of cloud-based therapeutic platforms and at-home VR devices. This model supports continuous engagement, allowing real-time progress tracking and therapist supervision. Increasing broadband penetration and wearable integration enhance the remote therapy experience. Furthermore, post-pandemic telehealth policies and reimbursement flexibility are accelerating patient adoption, fueling exponential segment expansion.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to rapid healthcare digitization, mental health awareness campaigns, and expanding telemedicine infrastructure. Countries like Japan, South Korea, and China are integrating VR therapy within psychiatric hospitals and wellness centers. Government initiatives supporting mental wellness technologies further bolster adoption. Rising disposable incomes and tech-savvy populations enhance regional uptake of immersive therapeutic solutions.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with strong technological innovation, early clinical adoption, and supportive regulatory frameworks. The U.S. and Canada lead in VR mental health research, supported by university trials and healthcare startups. Integration with insurance models and AI-driven analytics amplifies treatment precision. Additionally, increasing investment from digital health companies reinforces rapid market growth across the region.
Key players in the market
Some of the key players in Virtual-Reality Therapy Environments Market include XRHealth, Psious, Oxford VR, AppliedVR, Limbix, BehaVR, MindMaze, Pear Therapeutics, Virtually Better, Firsthand Technology, Emersa Health, Karuna Labs, Samsung, HP, Meta, and Google.
In October 2025, AppliedVR launched an upgraded version of its "EaseVRx" platform, improving the fidelity and personalization of its immersive pain distraction environments. The update now uses real-time biometric feedback (via integrated wearables) to dynamically adjust scene complexity and narrative pacing, enhancing non-pharmacological pain management for chronic conditions.
In September 2025, Oxford VR expanded its evidence-based "gameChange" therapy platform to the US market, now supporting a wider range of social anxiety and agoraphobia scenarios. The update includes AI-driven coaching avatars that provide personalized cognitive interventions within the VR environment, tailored to the user's in-session anxiety levels.
In August 2025, XRHealth & Meta announced a strategic partnership to deploy specialized therapeutic VR environments on the Meta Quest Pro platform for clinical and at-home use. The collaboration integrates XRHealth's clinical software with Meta's advanced eye and face tracking to better monitor patient engagement and emotional response during therapy sessions.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.